Olga Berson practices in the areas of life sciences, chemical and pharmaceutical litigation, including Abbreviated New Drug Application (ANDA) litigation, patent infringement cases, inventorship disputes and Section 337 actions before the US International Trade Commission. A registered patent attorney, Dr. Berson has considerable experience in the preparation and prosecution of patent applications. She counsels clients on worldwide patent portfolio management, strategic development and licensing. Her experience also involves preparation of patentability, freedom to operate, patent validity and non-infringement opinions as well as due diligence work in connection with acquisition and licensing of patent portfolios.

Dr. Berson received her Ph.D. in environmental science and chemistry from the California Institute of Technology (Caltech) for her study of bioremediation of an industrial solvent by stimulating growth of natural microbial populations. After graduation, she worked for three years as a senior scientist in a startup company. In all areas of her patent practice, Dr. Berson draws on her extensive technical training and research experience in a wide range of disciplines, including biology, chemistry, medicine, pharmacology and environmental science.

Dr. Berson has been recognized as a Rising Star for intellectual property and intellectual property litigation by Super Lawyers magazine (Southern California edition) in 2005 and 2008.

Representative Matters

• Representation of a biotech company in an inventorship dispute centering around peptidomimetic compounds discovered by phage display methods
• Representation of a branded pharmaceutical company in patent infringement litigation brought pursuant to the Hatch-Waxman Act to protect a local anesthetic drug against multiple ANDA applicants
• Representation of a pharmaceutical company in patent due diligence in connection with an acquisition of an Alzheimer's drug
• Representation of a pharmaceutical company in evaluation of a patent portfolio covering a type II diabetes drug
• Preparation of invalidity and freedom to operate opinions for a pharmaceutical company in connection with licensing of an insomnia small molecule drug
• Preparation of patent applications and managing worldwide patent portfolio for a biotech company covering peptide vaccines, high-throughput methods for production of vaccines and therapeutic compositions, and compositions for treating anthrax